// App-Quantinova.ai

250 : The effect of JAK inhibition on neutrophil killing, netosis and metabolism in rheumatoid arthritis

Researchers

Presenter

  • Susama Chokesuwattanaskul

Principal Investigators

  • Sangeetha Mangalakumaran

  • Elinor Chapman

  • Andrew Cross

  • Marie M Phelan

  • Lu-Yun Lian

  • Robert J Moots

  • Helen L Wright

Medical Centers

  • Institute of Integrative Biology, University of Liverpool, Liverpool, United Kingdom

  • School of Life Sciences, University of Liverpool, Liverpool, UNITED KINGDOM

  • MRC/ARUK Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Rheumatoid arthritis

Biomarkers

  • Proto-oncogene tyrosine-protein kinase ROS

Drug/Treatment

  • Baricitinib

  • Tasocitinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved